Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 1
1974 1
1975 1
1977 1
1978 1
1979 2
1980 7
1981 3
1982 3
1983 1
1984 3
1985 2
1986 6
1987 4
1988 8
1989 11
1990 20
1991 12
1992 13
1993 17
1994 19
1995 13
1996 18
1997 15
1998 19
1999 21
2000 23
2001 35
2002 34
2003 27
2004 45
2005 63
2006 63
2007 63
2008 61
2009 78
2010 88
2011 105
2012 96
2013 117
2014 105
2015 120
2016 123
2017 117
2018 143
2019 148
2020 196
2021 279
2022 278
2023 256
2024 77

Text availability

Article attribute

Article type

Publication date

Search Results

2,630 results

Results by year

Filters applied: . Clear all
Page 1
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Gerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, George TI, Gundabolu K, Hexner E, Hobbs GS, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, McMahon B, Mohan SR, Nadiminti KV, Oh S, Pardanani A, Podoltsev N, Rein L, Salit R, Stein BL, Talpaz M, Vachhani P, Wadleigh M, Wall S, Ward DC, Bergman MA, Hochstetler C. Gerds AT, et al. Among authors: mohan sr. J Natl Compr Canc Netw. 2022 Sep;20(9):1033-1062. doi: 10.6004/jnccn.2022.0046. J Natl Compr Canc Netw. 2022. PMID: 36075392
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Among authors: mohan s. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Chemi F, Pearce SP, Clipson A, Hill SM, Conway AM, Richardson SA, Kamieniecka K, Caeser R, White DJ, Mohan S, Foy V, Simpson KL, Galvin M, Frese KK, Priest L, Egger J, Kerr A, Massion PP, Poirier JT, Brady G, Blackhall F, Rothwell DG, Rudin CM, Dive C. Chemi F, et al. Among authors: mohan s. Nat Cancer. 2022 Oct;3(10):1260-1270. doi: 10.1038/s43018-022-00415-9. Epub 2022 Aug 8. Nat Cancer. 2022. PMID: 35941262 Free PMC article.
Suprachoroidal Hemorrhage.
Mohan S, Sadeghi E, Mohan M, Iannetta D, Chhablani J. Mohan S, et al. Ophthalmologica. 2023;246(5-6):255-277. doi: 10.1159/000533937. Epub 2023 Sep 2. Ophthalmologica. 2023. PMID: 37660688 Free article. Review.
Benign fleck retina.
Mohan S, Mohan S, Rajan M. Mohan S, et al. Oman J Ophthalmol. 2022 Nov 2;15(3):423-424. doi: 10.4103/ojo.ojo_262_21. eCollection 2022 Sep-Dec. Oman J Ophthalmol. 2022. PMID: 36760932 Free PMC article. No abstract available.
2,630 results